Indaptus Therapeutics, Inc. (INDP) vs Neurogene Inc. (NGNE)

Indaptus Therapeutics, Inc. and Neurogene Inc. are both Biotechnology companies. Indaptus Therapeutics, Inc. and Neurogene Inc. are of similar size ($625.4M and $606.8M). Across the 8 metrics below, Indaptus Therapeutics, Inc. leads on 4 and Neurogene Inc. on 4.

Valuation

Metric INDP NGNE Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 38.60 2.94 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (167.34%) (17.79%) (28.84%)
Free cash flow yield (3.35%) (13.76%) (23.03%)

Profitability

Metric INDP NGNE Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (318.04%) (45.32%) (57.72%)
Return on assets (163.84%) (41.02%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INDP NGNE Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 52.15% 0.93% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INDP NGNE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.48 10.64 4.73
Net debt to EBITDA 0.43 2.57 0.96

Dividend

Metric INDP NGNE Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric INDP NGNE Biotechnology median
Market cap 606.77m 625.36m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack